• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 85 of 100
Martin Shkreli, CEO Reviled for Drug Price Gouging, Arrested on Securities Fraud Charges
Health
Martin Shkreli Is Headed For a Major Showdown With Congress
By ReutersJanuary 22, 2016
BRITAIN-PHARMACEUTICAL-GSK
Finance
Five Charged in U.S. With Stealing Secrets From GlaxoSmithKline
By ReutersJanuary 21, 2016
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
Health
Valeant Vows to Make Its Drugs ‘Affordable’
By Laura LorenzettiJanuary 13, 2016
Biosimilars Are Coming After Big Pharma’s Bottom Line
Health
Biosimilars Are Coming After Big Pharma’s Bottom Line
By Laura LorenzettiJanuary 12, 2016
AbbVie Inc. To Buy Shire For $54.8 Billion
Health
Drugmaker Shire Is Buying Baxalta for $32 Billion
By ReutersJanuary 11, 2016
Pfizer In Merger Talks With Allergan PLC
Health
Pfizer Just Jacked Up Prices for All of These Drugs
By ReutersJanuary 9, 2016
AbbVie Inc. To Buy Shire For $54.8 Billion
Health
Shire’s Merger With Baxalta Merger Is Nearly Done
By ReutersJanuary 8, 2016
<> at Downsview Park on September 20, 2015 in Toronto, Canada.
Arts & Entertainment
Wu-Tang’s RZA Says He Doesn’t Care What Martin Shkreli Does with His Album
By Laura LorenzettiJanuary 6, 2016
New York Mets v Washington Nationals
Arts & Entertainment
Why These Baseball Stars Are Suing Al Jazeera
By Michal AddadyJanuary 6, 2016
Senate Permanent Subcommittee On Investigations Hearing On U.S. Corporate Tax Code
Health
Valeant Appoints Howard Schiller Interim CEO
By ReutersJanuary 6, 2016
AbbVie Inc. To Buy Shire For $54.8 Billion
Health
Shire-Baxalta $32 Billion Merger Talks Said to Advance
By Michal AddadyJanuary 3, 2016
US-CRIME-JUSTICE-SHKRELI
Health
Martin Shkreli’s Old Company Has Filed For Bankruptcy
By ReutersDecember 30, 2015
sb10065848dh-001
Tech
New Research Shows How the Liver Fights off Sugar Cravings
By Hilary BrueckDecember 29, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Leadership
Valeant Will Be Run by a Group of Executives Until Its CEO Returns
By ReutersDecember 28, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Leadership
Valeant CEO J. Michael Pearson Hospitalized for ‘Severe’ Pneumonia
By ReutersDecember 26, 2015
1...
  • 83
  • 84
  • 85
  • 86
  • 87
...100
Most Popular
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeSeptember 20, 2026
Success
'Skills nobody can take': Meet a 20-year-old with a 4.5 GPA who skipped college for technical school to land an 'AI-proof' careerplaceholder alt text
By Muskaan ArshadSeptember 22, 2026
Success
Meet a 71-year-old who retired as a radiologist and professor, and now runs a banana-skewer business: ‘I never want to retire. Why would you do that?’placeholder alt text
By Preston ForeSeptember 20, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.